Physician profile
Katherine E Denison
NPI 1396426292
$1,642.80
in general payments reported to CMS, 2019-2025
12 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,198 · 2024: $196 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $913 · Food and Beverage: $655 · Education: $74.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $913.46 |
| Food and Beverage | $655.34 |
| Education | $74.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,094.81 | 2023 | Venclose Maven Catheter |
| Pfizer INC. | $161.29 | 2024-2025 | |
| Angiodynamics, INC. | $80.67 | 2023 | Auryon Laser System 100-120 Vac |
| Seagen INC. | $74.00 | 2024 | |
| W. L. Gore & Associates, INC. | $52.97 | 2024 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Astrazeneca Pharmaceuticals LP | $32.68 | 2025 | Enhertu |
| Abbvie INC. | $30.79 | 2025 | |
| Pharmacosmos Therapeutics INC. | $30.48 | 2025 | Monoferric |
| Gilead Sciences, INC. | $25.13 | 2025 | Trodelvy |
| Boston Scientific Corporation | $22.57 | 2023 | Varithena Administration Pack |
| Silk Road Medical, INC. | $21.07 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Daiichi Sankyo INC. | $16.34 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Denison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.